PortfoliosLab logo
INSP vs. RMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INSP and RMD is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

INSP vs. RMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%500.00%600.00%700.00%800.00%NovemberDecember2025FebruaryMarchApril
536.75%
160.32%
INSP
RMD

Key characteristics

Sharpe Ratio

INSP:

-0.47

RMD:

0.75

Sortino Ratio

INSP:

-0.28

RMD:

1.35

Omega Ratio

INSP:

0.96

RMD:

1.19

Calmar Ratio

INSP:

-0.52

RMD:

0.78

Martin Ratio

INSP:

-1.05

RMD:

3.58

Ulcer Index

INSP:

30.44%

RMD:

8.16%

Daily Std Dev

INSP:

67.90%

RMD:

38.77%

Max Drawdown

INSP:

-61.59%

RMD:

-61.60%

Current Drawdown

INSP:

-51.22%

RMD:

-18.21%

Fundamentals

Market Cap

INSP:

$4.71B

RMD:

$34.68B

EPS

INSP:

$1.87

RMD:

$8.92

PE Ratio

INSP:

84.60

RMD:

26.47

PS Ratio

INSP:

5.86

RMD:

6.91

PB Ratio

INSP:

6.40

RMD:

6.00

Total Revenue (TTM)

INSP:

$638.79M

RMD:

$5.02B

Gross Profit (TTM)

INSP:

$540.57M

RMD:

$2.94B

EBITDA (TTM)

INSP:

$79.40M

RMD:

$1.65B

Returns By Period

In the year-to-date period, INSP achieves a -14.20% return, which is significantly lower than RMD's 3.38% return.


INSP

YTD

-14.20%

1M

-2.53%

6M

-18.51%

1Y

-31.15%

5Y*

17.11%

10Y*

N/A

RMD

YTD

3.38%

1M

6.31%

6M

-7.48%

1Y

29.77%

5Y*

8.88%

10Y*

15.30%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INSP vs. RMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSP
The Risk-Adjusted Performance Rank of INSP is 2626
Overall Rank
The Sharpe Ratio Rank of INSP is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of INSP is 2929
Sortino Ratio Rank
The Omega Ratio Rank of INSP is 2828
Omega Ratio Rank
The Calmar Ratio Rank of INSP is 1818
Calmar Ratio Rank
The Martin Ratio Rank of INSP is 2626
Martin Ratio Rank

RMD
The Risk-Adjusted Performance Rank of RMD is 7878
Overall Rank
The Sharpe Ratio Rank of RMD is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 7575
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 7676
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 8080
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INSP vs. RMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Medical Systems, Inc. (INSP) and ResMed Inc. (RMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for INSP, currently valued at -0.47, compared to the broader market-2.00-1.000.001.002.003.00
INSP: -0.47
RMD: 0.75
The chart of Sortino ratio for INSP, currently valued at -0.28, compared to the broader market-6.00-4.00-2.000.002.004.00
INSP: -0.28
RMD: 1.35
The chart of Omega ratio for INSP, currently valued at 0.96, compared to the broader market0.501.001.502.00
INSP: 0.96
RMD: 1.19
The chart of Calmar ratio for INSP, currently valued at -0.52, compared to the broader market0.001.002.003.004.005.00
INSP: -0.52
RMD: 0.78
The chart of Martin ratio for INSP, currently valued at -1.05, compared to the broader market-5.000.005.0010.0015.0020.00
INSP: -1.05
RMD: 3.58

The current INSP Sharpe Ratio is -0.47, which is lower than the RMD Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of INSP and RMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.47
0.75
INSP
RMD

Dividends

INSP vs. RMD - Dividend Comparison

INSP has not paid dividends to shareholders, while RMD's dividend yield for the trailing twelve months is around 0.88%.


TTM20242023202220212020201920182017201620152014
INSP
Inspire Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RMD
ResMed Inc.
0.88%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%

Drawdowns

INSP vs. RMD - Drawdown Comparison

The maximum INSP drawdown since its inception was -61.59%, roughly equal to the maximum RMD drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for INSP and RMD. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2025FebruaryMarchApril
-51.22%
-18.21%
INSP
RMD

Volatility

INSP vs. RMD - Volatility Comparison

Inspire Medical Systems, Inc. (INSP) has a higher volatility of 18.59% compared to ResMed Inc. (RMD) at 14.81%. This indicates that INSP's price experiences larger fluctuations and is considered to be riskier than RMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
18.59%
14.81%
INSP
RMD

Financials

INSP vs. RMD - Financials Comparison

This section allows you to compare key financial metrics between Inspire Medical Systems, Inc. and ResMed Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items